title: Value of pharmacokinetic studies for patients with gastrointestinal stromal tumors.
authors.affiliation: Department of Oncology, IRCCS Istituto Scientifico Romagnolo per lo Studio & la Cura dei Tumori (IRST), Via Piero Maroncelli 40, 47014 Meldola (FC), Italy. u.degiorgi@irst.emr.it.
authors.forename: Ugo
authors.initials: U
authors.lastname: De Giorgi
mesh_terms: D000970:Antineoplastic Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D001549:Benzamides / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D007211:Indoles / Q000493:pharmacokinetics / Q000627:therapeutic use; D058990:Molecular Targeted Therapy; D010879:Piperazines / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011743:Pyrimidines / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011758:Pyrroles / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077210:Sunitinib
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D007211:Indoles; D010879:Piperazines; D011743:Pyrimidines; D011758:Pyrroles; D000068877:Imatinib Mesylate; D000077210:Sunitinib